Worth reading
69In focus
Scored from 4 of 6 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
—
Displayed only when the document provides numerical figures.Wording
Avoiding a definitive answer
How definitive the wording is.Contents of this document
Summary of Q&AFiscal year ending December 20258 items taken from the company’s own explanation
Financial Results Figures (The key points of this material are explained below)
Operating profit45.3 Operating margin %
Operating profit margin45.3
What the company explained in this material
Self-assessment against the planThe company's self-assessment against its own plan.
上場以来、計画は毎期達成し、中期経営計画も上振れさせてローリングしてきたKey points of the Q&AKey questions raised by investors at the briefing and the company's answers
診療報酬改定、AI訪問予定ルート、業績拡大要因、利益率、中期経営計画、BPaaS、成長投資・配当、データビジネス、海外展開、M&A、人材戦略、競争環境、セキュリティ、株主還元などNew initiatives
- AI訪問予定ルートの2026年7月課金開始
- けあログっとによる病院・在宅医療間の連携拡大
- 病院、診療所、薬局、歯科へのサービス領域拡大
- PHR・リアルワールドデータ活用の事業化準備
- 海外展開の可能性検討
- ヘルスケア領域で数十億円程度の中小型M&Aを柔軟に検討
- 2026年度の従業員数151名への拡大
Key KPIsA metric the company considers important as a management benchmark.
- AI訪問予定ルート無料申込件数1,295 EngagementsYear on year against the same period last yearContinued Increase
- AI訪問予定ルート有料契約率見通し10~15
- BPaaSの売上総利益に対する割合(2025年12月期)10.7 %
- BPaaSの売上総利益に対する割合(2026年12月期予定)12.2 %
- 女性幹部社員比率33 %Year on year against the same period last yearHigher
- Proportion of Female Officers25 %
Unit price and quantity metricsThese figures show sales broken down by price and volume.
- AI訪問予定ルート無料申込件数1,295 Engagements
- AI訪問予定ルート有料契約率見通し10~15
- iBow課金体系100 1訪問あたり100円
Medium-term management plan targets
2025年度のAI訪問看護計画・報告やBPaaSの好調を反映し、前回計画から売上を増加させる計画。10年後に在宅医療プラットフォーマーを目指すNumber of employees
Number of Employees2025年度末107名、2026年度計画151名
Changes during the period and hiring plan44名増加計画、採用を強化
Payout ratio
20| Item | Details |
|---|---|
| Document type | Summary of Q&A |
| Fiscal Period Covered | Fiscal year ending December 2025 |
| Operating profit | 45.3 Operating margin (%) |
| Operating profit margin | 45.3 |
| Self-assessment against the plan | 上場以来、計画は毎期達成し、中期経営計画も上振れさせてローリングしてきた |
| Key KPIs | Indicator name AI訪問予定ルート無料申込件数 / Value 1,295 Engagements / Year on year against the same period last year Continued Increase, Indicator name AI訪問予定ルート有料契約率見通し / Value 10~15 / Year on year against the same period last year Not disclosed, Indicator name BPaaSの売上総利益に対する割合(2025年12月期) / Value 10.7 % / Year on year against the same period last year Not disclosed, Indicator name BPaaSの売上総利益に対する割合(2026年12月期予定) / Value 12.2 % / Year on year against the same period last year Not disclosed, Indicator name 女性幹部社員比率 / Value 33 % / Year on year against the same period last year Higher, Indicator name Proportion of Female Officers / Value 25 % / Year on year against the same period last year Not disclosed |
| Unit price and quantity metrics | Indicator name AI訪問予定ルート無料申込件数 / Value 1,295 Engagements, Indicator name AI訪問予定ルート有料契約率見通し / Value 10~15, Indicator name iBow課金体系 / Value 100 1訪問あたり100円 |
| Number of employees | Number of Employees 2025年度末107名、2026年度計画151名 / Changes during the period and hiring plan 44名増加計画、採用を強化 |
| Medium-term management plan targets | 2025年度のAI訪問看護計画・報告やBPaaSの好調を反映し、前回計画から売上を増加させる計画。10年後に在宅医療プラットフォーマーを目指す |
| Payout ratio | 20 |
| Key points of the Q&A | 診療報酬改定、AI訪問予定ルート、業績拡大要因、利益率、中期経営計画、BPaaS、成長投資・配当、データビジネス、海外展開、M&A、人材戦略、競争環境、セキュリティ、株主還元など |
| New initiatives | AI訪問予定ルートの2026年7月課金開始, けあログっとによる病院・在宅医療間の連携拡大, 病院、診療所、薬局、歯科へのサービス領域拡大, PHR・リアルワールドデータ活用の事業化準備, 海外展開の可能性検討, ヘルスケア領域で数十億円程度の中小型M&Aを柔軟に検討, 2026年度の従業員数151名への拡大 |
Items this document does not state (19)
Net SalesOrdinary incomeNet incomeGross Profit MarginSelling, general and administrative expensesResults for the three months of the current quarterFull-year earnings forecastProgress against full-year forecastSegment resultsBreakdown of Factors Affecting the ChangeNumber of stores and locationsAssumptions Underlying the Business OutlookRisk amount incorporated into the outlookFinancial targetsAnnual DividendAcquisition of treasury sharesCapital expendituresOrders received and order backlogMarket Size / Share
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.決算説明会での質疑内容を投資家向けに公開するため。内容は質問の統合・取捨選択などを行った要旨であると説明している。
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.